Drilldown: Medicines - Pharmacopedia

Nav

Choose a table:

Medicines (732)

Medicines > generic: Insulin glargine

& classes: [[:Category:Basal_insulins|Basal insulin]]

& fda max: Titrated to glucose; no fixed ceiling

Use the filters below to narrow your results.

Lantus, Basaglar, Semglee, Toujeo (U-300) (1)

'"`UNIQ--vote-00000237-QINU`"' Binds the same insulin receptor as endogenous insulin with comparable mitogenic-to-metabolic ratio; provides basal hepatic glucose suppression and peripheral glucose uptake without prandial peaks'"`UNIQ--ref-00000238-QINU`"'. (1)

'"`UNIQ--vote-00000239-QINU`"', '"`UNIQ--vote-0000023A-QINU`"' (1)

~10 units SC at the same time daily, or 0.1-0.2 units/kg/d; titrate by fasting glucose (1)

100 U/mL (Lantus, Basaglar, Semglee) vials and pens; 300 U/mL (Toujeo) pens (1)

Subcutaneous (never IV; not for use in insulin pumps) (1)

1-2 hours (1)

~24 hours per dose (peakless profile by design) (1)

~12 hours apparent (functional duration ~24 hours due to depot release kinetics)'"`UNIQ--ref-0000023B-QINU`"' (1)

~100% from subcutaneous depot (by definition of the route) (1)

Insulin is the preferred glucose-lowering therapy in pregnancy; glargine has reassuring observational data, though NPH and detemir remain the traditional choices.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)

[[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 1 result in range #1 to #1.

I

Insulin Glargine

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"